Diferencia entre revisiones de «Hirudins»
Sin resumen de edición |
(→Drugs) |
||
| (No se muestran 2 ediciones intermedias de 2 usuarios) | |||
| Línea 5: | Línea 5: | ||
*Hirudin | *Hirudin | ||
*Lepirudin | *Lepirudin | ||
*Argatroban | *[[Argatroban]] | ||
==Indications== | ==Indications== | ||
| Línea 24: | Línea 24: | ||
==References== | ==References== | ||
<references/> | |||
[[Category: | [[Category:Pharmacology]] | ||
[[Category:Heme/Onc]] | [[Category:Heme/Onc]] | ||
Revisión actual - 20:22 22 sep 2019
Background
- Direct thrombin inhibitors
Drugs
- Hirudin
- Lepirudin
- Argatroban
Indications
- HIT
- Unstable angina/NSTEMI/PCI
Complications
- Bleeding
- Majority of bleeding events occur at invasive sites
- No antidote available
- Minor bleeding
- Stop infusion
- Major bleeding
- Give FFP or PCC
Pharmacology
- Half-life is ~2hr